Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In vitro pharmalogic rationale for intraperitoneal regional chemotherapy

K H Link1, U Butzer, J Pillasch

  • 1Department of General Surgery, University Hospital of Ulm, Germany.

Cancer Treatment and Research
|January 1, 1996
PubMed
Summary

This study evaluated drug effectiveness for intraperitoneal regional chemotherapy (IPRC). In vitro tests on cell lines and tumor samples identified optimal drug concentrations and exposure times, improving drug selection for IPRC.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant.

Critical care medicine·2001
Same author

Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications.

Gut·2000
Same author

[The therapy of acute pancreatitis. General guidelines. Working group of the Society for Scientific-Medical Specialties].

Zeitschrift fur Gastroenterologie·2000
Same author

[Reconstruction after gastrectomy. Which patient benefits from a stomach substitute?].

MMW Fortschritte der Medizin·2000
Same author

Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy.

Cancer·2000
Same author

Endotoxin and antiendotoxin antibodies in patients with acute pancreatitis.

The European journal of surgery = Acta chirurgica·2000

Area of Science:

  • Oncology
  • Pharmacology
  • Experimental Therapeutics

Background:

  • Intraperitoneal regional chemotherapy (IPRC) requires precise drug selection and administration.
  • Understanding drug concentration-response and time-dependency is crucial for optimizing IPRC efficacy.
  • Existing data on drug behavior in IPRC settings is limited, necessitating preclinical evaluation.

Purpose of the Study:

  • To support the concept of intraperitoneal regional chemotherapy (IPRC).
  • To improve drug selection rationale for IPRC through in vitro studies.
  • To define concentration-response and time-dependency of cytotoxic drugs.

Main Methods:

  • In vitro studies using human colorectal carcinoma cell lines (HT29, NMG 64/84) and individual tumor cell suspensions.

Related Experiment Videos

  • Evaluation of drug cytotoxicity, concentration-response, and time-dependency for various chemotherapeutic agents.
  • In vitro phase II studies using the human tumor colony assay (HTCA) with solid tumor biopsies.

    • Main Results:

    • All tested drugs exhibited time- and concentration-dependent cytotoxic activity against cell lines.
    • Human tumor colony assay (HTCA) revealed varying cytotoxic concentration responses among drugs and individual tumor biopsies.
    • An overall increase in in vitro response by a factor of 2.1 +/- 0.7 was observed when comparing response rates at different concentrations.

    Conclusions:

    • In vitro studies successfully qualified various drugs for IPRC.
    • Optimal drug exposure times for IPRC were suggested based on cytotoxicity data.
    • These findings supported the successful clinical application of NOV in an IPRC study.